Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRent ExpenseResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Re (RMAX) EBITDA (2016 - 2026)

Re has reported EBITDA over the past 14 years, most recently at -$33.0 million for Q4 2025.

  • Quarterly EBITDA fell 777.54% to -$33.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $6.5 million through Dec 2025, down 84.68% year-over-year, with the annual reading at $6.5 million for FY2025, 84.68% down from the prior year.
  • EBITDA was -$33.0 million for Q4 2025 at Re, down from $18.9 million in the prior quarter.
  • Over five years, EBITDA peaked at $18.9 million in Q3 2025 and troughed at -$37.6 million in Q3 2021.
  • The 5-year median for EBITDA is $7.3 million (2022), against an average of $3.3 million.
  • Year-over-year, EBITDA surged 175.3% in 2024 and then crashed 777.54% in 2025.
  • A 5-year view of EBITDA shows it stood at $10.4 million in 2021, then decreased by 18.88% to $8.5 million in 2022, then tumbled by 214.58% to -$9.7 million in 2023, then skyrocketed by 150.22% to $4.9 million in 2024, then crashed by 777.54% to -$33.0 million in 2025.
  • Per Business Quant, the three most recent readings for RMAX's EBITDA are -$33.0 million (Q4 2025), $18.9 million (Q3 2025), and $14.6 million (Q2 2025).